KORRO BIO INC. - COMM

14.33

14-May-25 12:53:43

15 minutes delayed

Stocks

-1.22

-7.85%

Today's range

14.15 - 15.98

ISIN

N/A

Source

NASDAQ

Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference

20 May 2024 13:30:00 By Nasdaq GlobeNewswire
Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer

14 May 2024 15:01:00 By Nasdaq GlobeNewswire
Korro Announces $70 Million Private Placement

18 Apr 2024 07:30:59 By Nasdaq GlobeNewswire
Korro to Participate in Upcoming Investor Conferences

01 Apr 2024 15:01:00 By Nasdaq GlobeNewswire
Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress

26 Mar 2024 15:01:00 By Nasdaq GlobeNewswire
Korro to Present at the TD Cowen 44th Annual Health Care Conference

27 Feb 2024 07:00:01 By Nasdaq GlobeNewswire
Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio

18 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference

04 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

07 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.